Live from the Institute for Functional Medicine Annual International Conference 2019

Using psilocybin for anxiety, depression, addiction 

There is therapeutic potential in psilocybin, said Roland Griffiths, PhD, at the 2019 Institute for Functional Medicine Annual International Conference in San Antonio, Texas.

Psilocybin is the principal psychoactive component the Psilocybegenus of mushrooms. The classic psychedelics are a structurally diverse group of compounds that bind at 5-HT2 Aserotonin receptors and produce a unique profile of changes in thoughts, perceptions, and emotions. Examples include the tryptamines and phenethylamines, Griffiths said.

Read more.